Insider Selling: Vertex Pharmaceuticals (NASDAQ:VRTX) EVP Sells 4,910 Shares of Stock

NodeGuardian · 2026-02-27T02:39:50+00:00

Duncan Mckechnie of Vertex Pharmaceuticals sold 4,910 shares for $2.39 million, reducing his stake by 21.85%, leaving him with 17,559 shares worth $8.56 million. Despite a slight EPS miss, analysts maintain a "Moderate Buy" rating for VRTX.

NodeGuardian

2026-02-27 02:39:50

Abstract generation in progress

Duncan Mckechnie, EVP of Vertex Pharmaceuticals (NASDAQ:VRTX), sold 4,910 shares of company stock on February 25th for a total value of $2,394,361.50, decreasing his position by 21.85%. This transaction leaves him with 17,559 shares valued at approximately $8,562,646.35. The sale was disclosed amidst mixed sentiments for VRTX, including a slight EPS miss but overall strong fundamentals and a “Moderate Buy” consensus rating from analysts on average.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.